These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30121971)

  • 1. Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma.
    Joung JW; Oh HK; Lee SJ; Kim YA; Jung HJ
    J Pathol Transl Med; 2018 Sep; 52(5):323-330. PubMed ID: 30121971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
    Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
    Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M
    J Lifestyle Med; 2014 Mar; 4(1):64-70. PubMed ID: 26064856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma.
    Lin J; Tang Z; Zhang C; Dong W; Liu Y; Huang H; Liu H; Huang J; Lin T; Chen X
    Heliyon; 2023 May; 9(5):e16076. PubMed ID: 37215783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma.
    Oh S; Sung DJ; Yang KS; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB
    Acta Radiol; 2017 Mar; 58(3):376-384. PubMed ID: 27235451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma Prognosis.
    Qin C; Yin H; Liu H; Liu F; Du Y; Xu T
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33147753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
    Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
    Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
    Nishikimi T; Tsuzuki T; Fujita T; Sassa N; Fukatsu A; Katsuno S; Yoshino Y; Hattori R; Gotoh M
    Pathol Int; 2011 Mar; 61(3):116-21. PubMed ID: 21355952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
    Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
    Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
    Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
    Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.
    Sheela Devi CS; Suchitha S; Veerendrasagar RS
    Iran J Pathol; 2017; 12(2):150-157. PubMed ID: 29515637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.
    Park MJ; Baek HW; Rhee YY; Lee C; Park JW; Kim HW; Moon KC
    J Pathol Transl Med; 2015 Jan; 49(1):37-43. PubMed ID: 25812656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.